Quest PharmaTech, Inc. (QPT.V)
0.02
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Quest PharmaTech EPS Diluted (Quarterly) : 0.0201 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2026 | 0.0201 |
| October 31, 2025 | 0.0064 |
| July 31, 2025 | -0.001 |
| April 30, 2025 | 0.0041 |
| January 31, 2025 | -0.01 |
| October 31, 2024 | 0.0002 |
| July 31, 2024 | 0.0042 |
| April 30, 2024 | -0.0051 |
| January 31, 2024 | -0.0117 |
| October 31, 2023 | -0.0045 |
| July 31, 2023 | -0.001 |
| April 30, 2023 | -0.0006 |
| January 31, 2023 | -0.0281 |
| October 31, 2022 | -0.0054 |
| July 31, 2022 | -0.0036 |
| April 30, 2022 | -0.0062 |
| January 31, 2022 | -0.451 |
| October 31, 2021 | -0.0537 |
| July 31, 2021 | 0.0027 |
| April 30, 2021 | -0.0035 |
| January 31, 2021 | 0.4579 |
| October 31, 2020 | 0.0221 |
| July 31, 2020 | 0.019 |
| April 30, 2020 | 0.6335 |
| January 31, 2020 | -0.0111 |
| Date | Value |
|---|---|
| October 31, 2019 | -0.0096 |
| July 31, 2019 | -0.0063 |
| April 30, 2019 | -0.01 |
| January 31, 2019 | -0.0062 |
| October 31, 2018 | -0.0053 |
| July 31, 2018 | -0.009 |
| April 30, 2018 | -0.0062 |
| January 31, 2018 | -0.0113 |
| October 31, 2017 | -0.007 |
| July 31, 2017 | -0.008 |
| April 30, 2017 | -0.006 |
| January 31, 2017 | -0.01 |
| October 31, 2016 | -0.009 |
| July 31, 2016 | -0.007 |
| April 30, 2016 | -0.002 |
| January 31, 2016 | -0.029 |
| October 31, 2015 | -0.002 |
| July 31, 2015 | -0.005 |
| April 30, 2015 | -0.002 |
| January 31, 2015 | -0.0079 |
| October 31, 2014 | -0.003 |
| July 31, 2014 | -0.003 |
| April 30, 2014 | -0.004 |
| January 31, 2014 | 0.015 |
| October 31, 2013 | -0.006 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.0039 |
| BriaCell Therapeutics Corp. | -1.354 |
| Vaxil Bio Ltd. | -0.0161 |
| Waverley Pharma, Inc. | -0.0031 |
| Goldcoast Resource Corp. | -0.0725 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.401M |
| Total Expenses (Quarterly) | -3.401M |
| Enterprise Value | 4.368M |
| Earnings Yield | 148.0% |
| Normalized Earnings Yield | 91.50 |